Editing Blepharitis (section)

== Treatment ==
[[File:Warm compress.jpg|thumb|right|Microwavable warm compresses for daily loop treatment]]

Blepharitis is a chronic condition causing frequent exacerbation, thus requiring routine eyelid hygiene. Hygienic practices include warm compresses, eyelid massages, and eyelid scrubs.<ref name=":0" /> A [[Cochrane Collaboration|Cochrane Systematic Review]] found topical antibiotics to be effective in providing symptomatic relief and clearing bacteria for individuals with anterior blepharitis.<ref name="Lindsley2">{{cite journal | vauthors = Lindsley K, Matsumura S, Hatef E, Akpek EK | title = Interventions for chronic blepharitis | journal = The Cochrane Database of Systematic Reviews | volume = 2012 | issue = 5 | pages = CD005556 | date = May 2012 | pmid = 22592706 | pmc = 4270370 | doi = 10.1002/14651858.CD005556.pub2 }}</ref> Topical steroids provided some symptomatic relief, but they were ineffective in clearing bacteria from the eyelids.<ref name="Lindsley2" /> Lid hygiene measures such as [[warm compresses]] and lid scrubs were found to be effective in providing symptomatic relief for participants with anterior and posterior blepharitis.<ref name="Lindsley2" /> [[BlephEx]] is a handheld medical device used by a doctor to exfoliate eyelids<ref name="King5.com">{{cite web |last1=Enersen |first1=Jean |title=New treatment for 'gritty eyes' |url=http://www.king5.com/story/news/health/body/2014/10/06/blepharitis-gritty-eyes-blephex/16832759/ |accessdate=8 April 2015 |website=King5.com |publisher=Gannett}}</ref> to treat blepharitis.<ref name="Ophthalmology">{{cite web |last1=Stevenson |first1=Sheryl |title=BlephEx introduces medical device for blepharitis |url=http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/news/blephex-introduces-medical-device-blepharitis?page=full |url-status=dead |archive-url=https://web.archive.org/web/20150427162108/http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/news/blephex-introduces-medical-device-blepharitis?page=full |archive-date=27 April 2015 |accessdate=8 April 2015 |website=Ophthalmology Times |publisher=Modern Medicine}}</ref>

[[Lotilaner]] (Xdemvy) was approved for medical use in the United States in July 2023, for the treatment of ''Demodex'' blepharitis.<ref>{{cite press release | title=FDA Approves Xdemvy (lotilaner ophthalmic solution) 0.25% for the treatment of Demodex blepharitis | publisher=Tarsus Pharmaceuticals | via=GlobeNewswire | date=25 July 2023 | url=https://www.globenewswire.com/en/news-release/2023/07/25/2710273/0/en/FDA-Approves-XDEMVY-lotilaner-ophthalmic-solution-0-25-for-the-treatment-of-Demodex-blepharitis.html | access-date=5 August 2023}}</ref>